ACS Central Science (Feb 2022)
Evaluation of SARS-CoV‑2 Main Protease Inhibitors Using a Novel Cell-Based Assay
- Wenyue Cao,
- Chia-Chuan Dean Cho,
- Zhi Zachary Geng,
- Namir Shaabani,
- Xinyu R. Ma,
- Erol C. Vatansever,
- Yugendar R. Alugubelli,
- Yuying Ma,
- Sankar P. Chaki,
- William H. Ellenburg,
- Kai S. Yang,
- Yuchen Qiao,
- Robert Allen,
- Benjamin W. Neuman,
- Henry Ji,
- Shiqing Xu,
- Wenshe Ray Liu
Affiliations
- Wenyue Cao
- Texas A&M Drug Discovery Laboratory, Department of Chemistry, Texas A&M University, College Station, Texas, United States
- Chia-Chuan Dean Cho
- Texas A&M Drug Discovery Laboratory, Department of Chemistry, Texas A&M University, College Station, Texas, United States
- Zhi Zachary Geng
- Texas A&M Drug Discovery Laboratory, Department of Chemistry, Texas A&M University, College Station, Texas, United States
- Namir Shaabani
- Sorrento Therapeutics, Inc., San Diego, California, United States
- Xinyu R. Ma
- Texas A&M Drug Discovery Laboratory, Department of Chemistry, Texas A&M University, College Station, Texas, United States
- Erol C. Vatansever
- Texas A&M Drug Discovery Laboratory, Department of Chemistry, Texas A&M University, College Station, Texas, United States
- Yugendar R. Alugubelli
- Texas A&M Drug Discovery Laboratory, Department of Chemistry, Texas A&M University, College Station, Texas, United States
- Yuying Ma
- Texas A&M Drug Discovery Laboratory, Department of Chemistry, Texas A&M University, College Station, Texas, United States
- Sankar P. Chaki
- Global Health Research Complex, Division of Research, Texas A&M University, College Station, Texas, United States
- William H. Ellenburg
- Texas A&M Drug Discovery Laboratory, Department of Chemistry, Texas A&M University, College Station, Texas, United States
- Kai S. Yang
- Texas A&M Drug Discovery Laboratory, Department of Chemistry, Texas A&M University, College Station, Texas, United States
- Yuchen Qiao
- Texas A&M Drug Discovery Laboratory, Department of Chemistry, Texas A&M University, College Station, Texas, United States
- Robert Allen
- Sorrento Therapeutics, Inc., San Diego, California, United States
- Benjamin W. Neuman
- Department of Biology, Texas A&M University, College Station, Texas, United States
- Henry Ji
- Sorrento Therapeutics, Inc., San Diego, California, United States
- Shiqing Xu
- Texas A&M Drug Discovery Laboratory, Department of Chemistry, Texas A&M University, College Station, Texas, United States
- Wenshe Ray Liu
- Texas A&M Drug Discovery Laboratory, Department of Chemistry, Texas A&M University, College Station, Texas, United States
- DOI
- https://doi.org/10.1021/acscentsci.1c00910
- Journal volume & issue
-
Vol. 8,
no. 2
pp. 192 – 204
Abstract
No abstracts available.